Research programme: pain therapy - Merck/Banyu
Alternative Names: Comp B; J 113397Latest Information Update: 29 Aug 2011
At a glance
- Originator Banyu; Merck & Co
- Class Benzimidazoles; Piperidines; Small molecules
- Mechanism of Action Nociceptin receptor antagonists; Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Pain; Traumatic stress disorders
Most Recent Events
- 29 Aug 2011 No development reported - Preclinical for Pain in Japan (SC)
- 29 Aug 2011 No development reported - Preclinical for Stress disorders in Japan (IV)
- 19 Nov 2008 Preclinical trials in Stress disorders in Japan (IV)